Navigation Links
Perrigo Reports Record Fourth Quarter and Fiscal Year Revenue, Earnings and Cash Flow From Operations
Date:8/16/2012

s AdjustedGAAPAs AdjustedNet sales

$
483,982$
-$
483,982$
433,813$
-$
433,81312 %12 %Cost of sales

333,9251,008

(a)

332,917300,4291,031

(a)

299,39811 %11 %Gross profit

150,0571,008151,065133,3841,031134,41513 %12 %Operating expenses

70,7461,419

(a)

69,32759,2042,265

(a,b)

56,93919 %22 %Operating income

$
79,311$
2,427$
81,738$
74,180$
3,296$
77,4767 %6 %Selected ratios as a percentage of net salesGross profit

31.0 %31.2 %30.7 %31.0 %Operating expenses

14.6 %14.3 %13.6 %13.1 %Operating income

16.4 %16.9 %17.1 %17.9 %Fiscal Year EndedConsumer HealthcareJune 30, 2012June 25, 2011% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales

$   1,815,788$
-$  1,815,788$   1,684,938$
-$
,684,9388 %8 %Cost of sales

1,255,5954,046

(a)

1,251,5491,153,5483,445

(a)

1,150,1039 %9 %Gross profit

560,1934,046564,239531,3903,445534,8355 %5 %Operating expenses

264,5405,267

(a)

259,273238,2935,975

(a,b)

232,31811 %12 %Operating income

$
295,653$
9,313$
304,966$
293,097$
9,420$
302,5171 %1 %Selected ratios as a percentage of net salesGross profit

30.9 %31.1 %31.5 %31.7 %Operating expenses

14.6 %14.3 %14.1 %13.8 %Operating income

16.3 %16.8 %17.4 %18.0 %Three Months EndedNutritionalsJune 30, 2012June 25, 2011% ChangeGAAPNon-GAAP AdjustmentsAs AdjustedGAAPNon-GAAP AdjustmentsAs AdjustedGAAPAs AdjustedNet sales

$
35,335$
-$
35,335$
23,130$
-$
23,13010 %10 %Cost of sales

96,9633,021

(a)

93,94285,6683,000

(a)

8
'/>"/>

SOURCE Perrigo Company
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Perrigo Receives FDA Approval And Commences Launch Of Morphine Sulfate 100ml/5% Oral Solution
2. China Biologic Reports Financial Results for the Second Quarter and First Half of 2012
3. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
4. Avanir Pharmaceuticals Reports Fiscal 2012 Third Quarter Financial And Business Results
5. Savient Pharmaceuticals Reports Second Quarter 2012 Financial Results
6. Origin Agritech Limited Reports Unaudited Third Quarter Financial Results For Three Months Ended June 30, 2012
7. Verenium Reports Financial Results For The Second Quarter And Six Months Ended June 30, 2012
8. Cadence Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. Discovery Labs Reports Second Quarter 2012 Financial Results
10. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
11. Cambrex Reports Second Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Scientists at the Center for Learning and ... the California -based biopharmaceutical company Magceutics, ... for reversing memory decline in mice with Alzheimer,s Disease. ... improvement in advanced stage AD mice. The study is ... decline for advanced stage AD mice, and is also ...
(Date:5/16/2013)... Toronto, Canada (PRWEB) May 16, 2013 ... years and costs over one billion dollars. Despite this ... market. With stakes this high, is your clinical trial ... and deliver the best outcomes? , Dr. Frederic Sax, ... Quintiles, will discuss the use of data, information and ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... for Acute Coronary Syndromes - APAC ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic MediPoint: ... Syndromes - APAC Analysis and Market ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products for ... program in conjunction with the African Society of Human Genetics ... reduce the cost of DNA collection for locally ... and Health in Africa (H3 Africa) Initiative and to facilitate ... the AfSHG is to build the capacity of ...
Breaking Biology Technology:Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Application in the ... European Union, ... Food and Drug Administration (FDA) has approved the design of,a single, ... with chemotherapy as first-line,treatment in patients with non-small cell lung cancer ...
... the aim of a new licensing deal between the ... and the company, based in West Sacramento, Calif., have ... of jointly-owned intellectual property stemming from inventions both on ... enable manufacture of very thin, very small wires, films ...
... 16 Roche (OTCQX:,RHHBY; SWX: ROG.VX; RO.S), a world-leading ... has extended its,offer to acquire all of the outstanding ... ) to 5:00 p.m., New York City time on ... to expire at 5:00,p.m., New York City time, on ...
Cached Biology Technology:Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 2Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 3Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 4Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 5Solar energy technology licensed 2Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4Roche Extends Tender Offer for Ventana 5
(Date:5/16/2013)... at sites outside the bone marrow in the ... in Munich now show that a specific type of ... cells. , Balanced hematopoiesis is essential for the function ... place mainly in the liver and the spleen. Later ... this tissue normally serves as the sole source of ...
(Date:5/16/2013)... Enang Abwe, a conservationist working in Cameroon and the ... has just been awarded the prestigious Whitley award. ... often called "The Green Oscars" because it celebrates the ... working in developing countries. Abwe was selected for ... and preserve Cameroon,s Ebo Forest and its wildlife inhabitants., ...
(Date:5/16/2013)... Germany , May 16, 2013 ... Value Enhancement Award on Tuesday to Germany,s ... its exceptional biometric border control system. DERMALOG ... with the Best Practices Award in the category Global ... its cutting edge Biometric   Border Control System ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... (highly active anti-retroviral therapy) has emerged as an extremely ... however, HAART can never truly eradicate the virus as ... chemical called suberoylanilide hydroxamic acid (SAHA), recently approved as ... on, latent HIV, making it an attractive candidate to ...
... MARCH 16, 2009--Throughout the world, nitrogen compounds are ... combustion of fossil fuels. These pollutants are deposited ... many hundreds of miles downwind of their release ... are a case in pointthough they contain little ...
... Researchers at the Johns Hopkins Bloomberg School of ... broiler poultry operations may contribute to the dispersion ... for human exposure to drug-resistant bacteria. The findings ... production and exposures to antibiotic resistant pathogens. Previous ...
Cached Biology News:Tree species composition influences nitrogen loss from forests 2Flies may spread drug-resistant bacteria from poultry operations 2
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Acrylamide PAGE 40% Solution, 1 l. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
Recombinant Mouse IL-23, CF...
Biology Products: